In the SURMOUNT-1 trial, also published in the NEJM , the results were even more striking
Other Common Ingredients: Weak Evidence, Strong Marketing Several other compounds appear regularly in GLP-1 supplement formulations, typically with minimal evidence for the specific claims made: Chromium Picolinate Marketed for insulin sensitivity and glucose metabolism, chromium shows weak and inconsistent evidence
There is significant research citing a connection between a deficiency in the MTHFR enzyme caused by a mutation in the MTHFR gene and increased prevalence and risk for psychiatric disorders such as schizophrenia and major depressive disorder
Given these differences, selecting the right GLP-1RA should be based on individual patient needs, including glycemic targets, weight loss goals, tolerability, and preference for dosing frequency
If it is cosmetic, our aesthetics team can discuss approaches without these risks